Moolec Science SA Form 6-K Summary
Business Context and Reporting Period
Moolec Science SA, a foreign private issuer based in Luxembourg, filed this Form 6-K on January 31, 2025. The filing serves to incorporate by reference unaudited interim condensed consolidated financial statements into the Company's registration statements on Form F-3 and Form S-8.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references Exhibit 99.1, which contains the unaudited interim condensed consolidated financial statements as of September 30, 2024, and June 30, 2024, and for the three-month periods ended September 30, 2024, and 2023.
Material Changes
The provided text does not contain a narrative discussion of material changes versus prior periods. Investors must refer to the referenced financial statements in Exhibit 99.1 for comparative data between the periods ended September 30, 2024, and September 30, 2023.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document is primarily a procedural filing to attach financial exhibits.
Key Facts for Investor Verification
- Verify the specific financial figures in Exhibit 99.1, as the Form 6-K text only references these statements without summarizing the data.
- Confirm the Company's status as a registrant filing under Form 20-F.
- Note that the financial data provided in the referenced exhibit is unaudited.
- Check the registration statements on Form F-3 (No. 333-283113) and Form S-8 (No. 333-282263) for the full context of the incorporated financials.